百晓学者学者目录

陈发林

教授,福州大学

精选作品

期刊论文

2024

血清外泌体hsa_circ_0001439、hsa_circ_0001492、hsa_circ_0000896在肺腺癌中的筛查价值

陈贝娥,曹鹏驹,陈发林

《临床检验杂志》

2024

中性粒细胞源性外泌体促进肺腺癌细胞的迁移和侵袭

李玲,陈佳豪,陈发林,陈良远

《福建医药杂志》

2022

Plasma tRF-1:29-Pro-AGG-1-M6 and tRF-55:76-Tyr-GTA-1-M2 as novel diagnostic biomarkers for lung adenocarcinoma

J. You, Guoliu Yang, Yi Wu, Xuan Lu, Shu-Yu Huang, Qian-Shun Chen, Chen Huang, Falin Chen, Xun-Yu Xu, Liangyuan Chen

Frontiers in Oncology

2022

Cancer-testis antigen KK-LC-1 is a potential biomarker associated with immune cell infiltration in lung adenocarcinoma

Yanli Kang, Yuhan Gan, Yi-Ming Jiang, J. You, Chen Huang, Qian-Shun Chen, Xun-Yu Xu, Falin Chen, Liangyuan Chen

BMC Cancer

2022

High expression of DARS2 indicates poor prognosis in lung adenocarcinoma

Yingfeng Jiang, J. You, Chuncai Wu, Yanli Kang, Falin Chen, Liangyuan Chen, Wenbing Wu

Journal of clinical laboratory analysis (Print)

2022

Overexpression of SFXN1 indicates poor prognosis and promotes tumor progression in lung adenocarcinoma.

Liangyuan Chen, Yanli Kang, Yi-Ming Jiang, J. You, Chen Huang, Xun-Yu Xu, Falin Chen

Pathology, Research and Practice

2022

Serum and Serum Exosomal CircRNAs hsa_circ_0001492, hsa_circ_0001439, and hsa_circ_0000896 as Diagnostic Biomarkers for Lung Adenocarcinoma

Yanli Kang, J. You, Yuhan Gan, Qian-Shun Chen, Chen Huang, Falin Chen, Xun-Yu Xu, Liangyuan Chen

Frontiers in Oncology

2022

The diagnostic and prognostic value of pseudogene SIGLEC17P in lung adenocarcinoma and a preliminary functional study

Xiu-Qin Shen, Yanfen Zeng, Cai-Hong Yang, Lili Jiang, Shao-Ting Chen, Falin Chen, Pengju Cao

Cell Biology International

2022

Plasma Exosomal CXCL7 is a Potential Biomarker for Lung Adenocarcinoma.

Wen-Ting Fang, J. You, Qifeng Xu, Yingfeng Jiang, Haizhou Hu, Falin Chen, Liangyuan Chen

Clinical Laboratory

2021

基于癌症基因组图谱数据库分析芳香烃受体核转运体样2在肺腺癌中的表达及其预后意义

陈金花,赵秋荣,尤剑彬,陈发林

《中国当代医药》

2021

PASD1在肺腺癌组织中的表达与临床意义

余丽莉,尤剑彬,陈发林,陈良远

《中国肿瘤外科杂志》

2021

GPR37在肺腺癌中的表达及其临床意义

郭静,尤剑彬,曹鹏驹,陈发林

《中国当代医药》

2021

Identification of a RNA-Seq Based Prognostic Signature with Seven Immune-Related lncRNAs for Lung Adenocarcinoma.

J. You, Wen-Ting Fang, Qiurong Zhao, Li-Qing Chen, Liangyuan Chen, Falin Chen

Clinical Laboratory

2020

肺腺癌组织lncRNA FAM83A-AS1表达及临床意义数据库分析

李瑶,曹鹏驹,陈发林

《社区医学杂志》

2020

Cancer/testis antigen LDHC promotes proliferation and metastasis by activating the PI3K/Akt/GSK-3β-signaling pathway and the in lung adenocarcinoma.

Liangyuan Chen, Qiumei Wu, Xun-Yu Xu, Cai-Hong Yang, J. You, Falin Chen, Yanfen Zeng

Experimental Cell Research

2020

Four Low Expression LncRNAs are Associated with Prognosis of Human Lung Adenocarcinoma.

Xiu-Qin Shen, Qiumei Wu, Cai Yang, Q. Yan, Pengju Cao, Falin Chen

Clinical Laboratory

2020

Serum exosomal miR‐7977 as a novel biomarker for lung adenocarcinoma

Liangyuan Chen, Pengju Cao, Chunli Huang, Qiumei Wu, Shao-Ting Chen, Falin Chen

Journal of Cellular Biochemistry

2020

Circular RNAs expression profiles in plasma exosomes from early‐stage lung adenocarcinoma and the potential biomarkers

Falin Chen, Chunli Huang, Qiumei Wu, Lili Jiang, Shao-Ting Chen, Liangyuan Chen

Journal of Cellular Biochemistry

2019

肺腺癌细胞源性外泌体活化的人THP-1巨噬细胞促进肺癌细胞的侵袭

陈良远,杨阳,黄春莉,曹鹏驹,吴秋妹,陈少婷,陈发林

《细胞与分子免疫学杂志》

2019

[Human THP-1 macrophages activated by exosomes derived from lung adenocarcinoma cells promote lung cancer cell invasion].

Liangyuan Chen, Yang Yang, Chunli Huang, Pengju Cao, Qiumei Wu, Shao-Ting Chen, Falin Chen

Xi bao yu fen zi mian yi xue za zhi = Chinese journal of cellular and molecular immunology

2019

Overexpression of LncRNA-UCA1 Correlates with Lung Adenocarcinoma Progression and Poor Prognosis.

Liangyuan Chen, Pengju Cao, Qiumei Wu, Yiqing Guo, Yang Yang, Falin Chen

Clinical Laboratory

2018

Prognostic roles of mRNA expression of peroxiredoxins in lung cancer

Liangyuan Chen, Chunli Huang, Xiaojun Yang, Qiuqin Zhang, Falin Chen

OncoTargets and Therapy

2016

非小细胞肺癌38例血清miR-21、miR-146a表达的临床意义

陈少婷,郑振威,陈发林

《福建医药杂志》

2015

微小核糖核酸21与肺癌的研究进展

陈少婷,陈发林

《检验医学与临床》

此主页由公开资料整理,尚未经学者本人认领。